gene therapy trial - Robuta Search

https://www.biopharmadive.com/news/pfizer-duchenne-gene-therapy-phase-3-sarepta/592936/ Pfizer beats Sarepta to start of first late-stage Duchenne gene therapy trial | BioPharma Dive late stage duchenne pfizer https://www.bioworld.com/articles/725024-trogenix-raises-70m-series-a-for-glioblastoma-gene-therapy-trial?v=preview Trogenix raises £70M series A for glioblastoma gene therapy trial | BioWorld Newco Trogenix Ltd. has emerged from incubation and raised £70 million (US$94.1 million) in a series A, as it prepares the ground for a U.S/U.K. clinical... gene therapy trial raises https://www.statnews.com/2025/12/15/gene-therapy-capsida-biotherapeutics-clinical-trial-death-ramifications/ Gene therapy trial death unnerves promising area of brain research | STAT Dec 16, 2025 - Researchers fear a broad risk for any virus genetically designed to penetrate the blood-brain barrier after no hint of issues prior to Capsida trial death. gene therapy trial death area https://endpoints.news/advocates-urge-jj-to-put-everything-on-the-table-for-gene-therapy-despite-failed-trial/ Advocates urge J&J to ‘put everything on the table’ for gene therapy despite failed trial advocates urge j everything https://www.merative.com/blog/veristat-gene-therapy Gene therapy: How Veristat cut trial database costs by 30% Learn how Veristat, the global Science-First™ CRO, reduced gene therapy trial costs thanks to efficient patient data management with Zelta. gene therapy veristat cut trial https://www.statnews.com/2019/11/12/solid-biosciences-duchenne-gene-therapy-trial-halted-after-patient-suffers-serious-toxicity/ Solid's Duchenne gene therapy trial halted after patient suffers toxicity Nov 12, 2019 - This is the third time that the Cambridge, Mass.-based Solid has run into a serious safety problem with its gene therapy, called SGT-001. duchenne gene therapy solid https://www.statnews.com/2025/09/24/huntingtons-gene-therapy-uniqure/ Uniqure gene therapy for Huntington’s slowed disease progression in key trial Sep 24, 2025 - Results are likely to support the first approval of a genetic treatment for the rare neurodegenerative condition. gene therapy uniqure slowed key https://news.ufl.edu/2024/09/blindness-gene-therapy/ Gene therapy restores vision in first-ever trial for rare, inherited blindness News | University of... Patients born with a certain genetic blindness experienced the world in an entirely new way after a single treatment with gene therapy developed at UF. gene therapy restores vision https://www.clinicaltrialsarena.com/news/zhongmou-therapeutics-rp-gene-therapy-shows-promise-in-first-in-human-trial/ Zhongmou Therapeutics’ RP gene therapy shows promise in first-in-human trial - Clinical Trials... Nov 27, 2025 - Zhongmou’s gene therapy has shown promise in treating the symptoms of retinitis pigmentosa (RP) in a single-site trial in China. gene therapy shows promise rp